[1]
“Resistant arterial hypertension: clinical and pathogenetic peculiarities and predictors of therapy effectiveness”, UJC, vol. 26, no. 4, pp. 77–89, Oct. 2019, doi: 10.31928/1608-635X-2019.4.7789.